Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study.

Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller P, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K, Othman M, Gresele P.

Haematologica. 2019 Sep 26. pii: haematol.2019.227876. doi: 10.3324/haematol.2019.227876. [Epub ahead of print]

2.

An "unmodifiable" risk factor that has been modified.

Ronca V, Podda GM, Cattaneo M.

Intern Emerg Med. 2019 Aug 8. doi: 10.1007/s11739-019-02170-9. [Epub ahead of print] No abstract available.

PMID:
31396923
3.

Handling shock in idiopathic systemic capillary leak syndrome (Clarkson's disease) less is more: reply.

Wu MA, Colombo R, Podda GM, Cicardi M.

Intern Emerg Med. 2019 Jul 24. doi: 10.1007/s11739-019-02155-8. [Epub ahead of print] No abstract available.

PMID:
31342454
4.

Handling shock in idiopathic systemic capillary leak syndrome (Clarkson's disease): less is more.

Wu MA, Colombo R, Podda GM, Cicardi M.

Intern Emerg Med. 2019 Aug;14(5):723-730. doi: 10.1007/s11739-019-02113-4. Epub 2019 Jun 1.

PMID:
31154613
5.

Measurement of platelet count with different anticoagulants in thrombocytopenic patients and healthy subjects: accuracy and stability over time.

Podda GM, Pugliano M, Casazza G, Soru P, Scavone M, Vismara G, Cattaneo M.

Haematologica. 2019 Apr 19. pii: haematol.2019.222265. doi: 10.3324/haematol.2019.222265. [Epub ahead of print]

6.

In vitro variations of Mean platelet volume over time in blood samples collected in different anticoagulants from thrombocytopenic patients and healthy subjects.

Podda GM, Casazza G, Soru P, Scavone M, Vismara G, Cattaneo M.

Int J Lab Hematol. 2017 Dec;39(6):e151-e154. doi: 10.1111/ijlh.12745. Epub 2017 Oct 8. No abstract available.

PMID:
28990313
7.

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zúñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir GN, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P; European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders.

Haematologica. 2017 Jul;102(7):1192-1203. doi: 10.3324/haematol.2016.160754. Epub 2017 Apr 6.

8.

High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMI.

Podda GM, Cattaneo M.

Thromb Haemost. 2017 May 3;117(5):829. doi: 10.1160/TH17-03-0167. Epub 2017 Mar 30. No abstract available.

PMID:
28357443
9.

Prediction of high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndromes.

Podda GM, Grossi E, Palmerini T, Buscema M, Femia EA, Della Riva D, de Servi S, Calabrò P, Piscione F, Maffeo D, Toso A, Palmieri C, De Carlo M, Capodanno D, Genereux P, Cattaneo M.

Int J Cardiol. 2017 Aug 1;240:60-65. doi: 10.1016/j.ijcard.2017.03.074. Epub 2017 Mar 18.

PMID:
28343766
10.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

Birocchi S, Fiorelli EM, Podda GM.

N Engl J Med. 2016 Dec 22;375(25):2498-9. No abstract available.

PMID:
28009495
11.

Wrong guidelines: how to detect them and what to do in the case of flawed recommendations.

Iannone P, Costantino G, Montano N, Podda GM, Minardi M, Doyle J, Cartabellotta A.

Evid Based Med. 2017 Mar;22(1):4-8. doi: 10.1136/ebmed-2016-110607. Epub 2016 Dec 16.

PMID:
27986816
12.

Guidelines on the management of atrial fibrillation in the emergency department: a critical appraisal.

Costantino G, Podda GM, Falsetti L, Iannone P, Lages A, Marra AM, Masala M, Reiakvam OM, Savva F, Schovanek J, van Bree S, da Silva Chora IJ, Privitera G, Ragozzino S, von Rotz M, Woittiez L, Davidson C, Montano N.

Intern Emerg Med. 2017 Aug;12(5):693-703. doi: 10.1007/s11739-016-1580-x. Epub 2016 Nov 30.

PMID:
27905006
13.

Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage.

Birocchi S, Podda GM; GrAM (Gruppo di Auto formazione Metodologica).

Intern Emerg Med. 2017 Jun;12(4):527-529. doi: 10.1007/s11739-016-1568-6. Epub 2016 Nov 4. No abstract available.

PMID:
27815808
14.

Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders.

Lecchi A, Femia EA, Paoletta S, Dupuis A, Ohlmann P, Gachet C, Jacobson KA, Machura K, Podda GM, Zieger B, Cattaneo M.

Hamostaseologie. 2016 Nov 7;36(4):279-283. Epub 2016 Aug 4. Review.

15.

Is perioperative bridging anticoagulation useful in patients with atrial fibrillation?

Fiorelli EM, Podda GM; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2016 Mar;11(2):249-50. doi: 10.1007/s11739-015-1355-9. Epub 2015 Dec 11. No abstract available.

PMID:
26661621
16.

Platelet transfusion strategy for hematologic cancers.

Podda GM, Ricci S.

Intern Emerg Med. 2015 Feb;10(1):81-2. doi: 10.1007/s11739-014-1148-6. Epub 2014 Oct 31. No abstract available.

PMID:
25358897
17.

Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency.

Faioni EM, Razzari C, Zulueta A, Femia EA, Fenu L, Trinchera M, Podda GM, Pugliano M, Marongiu F, Cattaneo M.

Thromb Haemost. 2014 Dec;112(6):1182-9. doi: 10.1160/TH14-04-0352. Epub 2014 Aug 7.

PMID:
25102815
18.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

19.

Prediction of optimal warfarin maintenance dose using advanced artificial neural networks.

Grossi E, Podda GM, Pugliano M, Gabba S, Verri A, Carpani G, Buscema M, Casazza G, Cattaneo M.

Pharmacogenomics. 2014 Jan;15(1):29-37. doi: 10.2217/pgs.13.212.

PMID:
24329188
20.

ANKRD26-related thrombocytopenia and myeloid malignancies.

Noris P, Favier R, Alessi MC, Geddis AE, Kunishima S, Heller PG, Giordano P, Niederhoffer KY, Bussel JB, Podda GM, Vianelli N, Kersseboom R, Pecci A, Gnan C, Marconi C, Auvrignon A, Cohen W, Yu JC, Iguchi A, Miller Imahiyerobo A, Boehlen F, Ghalloussi D, De Rocco D, Magini P, Civaschi E, Biino G, Seri M, Savoia A, Balduini CL.

Blood. 2013 Sep 12;122(11):1987-9. doi: 10.1182/blood-2013-04-499319. No abstract available.

PMID:
24030261
21.

Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons.

Costantino G, Podda GM, Bonzi M, Sbrojavacca R; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2013 Dec;8(8):651-2. doi: 10.1007/s11739-013-0986-y. Epub 2013 Aug 23. No abstract available.

PMID:
23975391
22.

Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies.

Birocchi S, Scannella E, Ferrari L, Podda GM; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2013 Dec;8(8):757-60. doi: 10.1007/s11739-013-0961-7. Epub 2013 Jun 7. No abstract available.

PMID:
23744554
23.

Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency.

Bottega R, Pecci A, De Candia E, Pujol-Moix N, Heller PG, Noris P, De Rocco D, Podda GM, Glembotsky AC, Cattaneo M, Balduini CL, Savoia A.

Haematologica. 2013 Jun;98(6):868-74. doi: 10.3324/haematol.2012.075861. Epub 2012 Oct 25.

24.

Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.

Costantino G, Ceriani E, Rusconi AM, Podda GM, Montano N, Duca P, Cattaneo M, Casazza G.

PLoS One. 2012;7(9):e44553. doi: 10.1371/journal.pone.0044553. Epub 2012 Sep 11. Review.

25.

EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin.

Sakariassen KS, Femia EA, Daray FM, Podda GM, Razzari C, Pugliano M, Errasti AE, Armesto AR, Nowak W, Alberts P, Meyer JP, Sorensen AS, Cattaneo M, Rothlin RP.

Thromb Res. 2012 Nov;130(5):746-52. doi: 10.1016/j.thromres.2012.08.309. Epub 2012 Sep 5.

PMID:
22959706
26.

To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.

Birocchi S, Cernuschi G, Podda GM, Costantino G.

Intern Emerg Med. 2013 Apr;8(3):245-8. doi: 10.1007/s11739-012-0816-7. Epub 2012 Jul 31. No abstract available.

PMID:
22847728
27.

Addressing the management of atrial fibrillation - a systematic review of the role of dronedarone.

Podda GM, Casazza G, Casella F, Dipaola F, Scannella E, Tagliabue L.

Int J Gen Med. 2012;5:465-78. doi: 10.2147/IJGM.S16674. Epub 2012 May 28.

28.

The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories.

Podda GM, Pugliano M, Femia EA, Mezzasoma AM, Gresele P, Carpani G, Cattaneo M.

Am J Hematol. 2012 Jul;87(7):727-8. doi: 10.1002/ajh.23216. Epub 2012 Jun 3.

29.

Aspirin for the primary prevention of cardiovascular diseases.

Tagliabue L, Dipaola F, Perego F, Podda GM; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2012 Aug;7(4):375-9. doi: 10.1007/s11739-012-0791-z. Epub 2012 Jun 6. No abstract available.

PMID:
22669555
30.

Do procalcitonin algorithms modify mortality?

Ferrari L, Casella F, Podda GM; Gruppo di Autoformazione Metodologica (GRAM).

Arch Intern Med. 2012 Jan 23;172(2):197-8; author reply 198. doi: 10.1001/archinternmed.2011.764. No abstract available.

PMID:
22271136
31.

[Recent advances on the studies of the platelet's inhibition and aggregation. State of the art of new P2Y12 antagonists].

Cattaneo GJ, Podda GM, Cattaneo M.

Recenti Prog Med. 2011 Apr;102(4):150-5. doi: 10.1701/624.7286. Review. Italian.

PMID:
21572491
32.

Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosis.

Ferrari L, Podda GM.

Intern Emerg Med. 2011 Jun;6(3):261-2. doi: 10.1007/s11739-011-0593-8. Epub 2011 May 4. No abstract available.

PMID:
21541718
33.

Rosiglitazone plus metformin to prevent type 2 diabetes mellitus.

Ceriani E, Costantino G, Casazza G, Podda GM; GRAM (GRuppo Autoformazione Metodologica).

Lancet. 2010 Oct 23;376(9750):1387; author reply 1388. doi: 10.1016/S0140-6736(10)61947-2. No abstract available.

PMID:
20971354
34.

State of the art of new P2Y12 antagonists.

Cattaneo M, Podda GM.

Intern Emerg Med. 2010 Oct;5(5):385-91. doi: 10.1007/s11739-010-0363-z. Epub 2010 Feb 23. Review.

PMID:
20177818
35.

Can plasma levels of N-terminal pro-brain natriuretic peptide be useful in predicting the risk of developing chronic pulmonary hypertension in patients with pulmonary embolism?

Lussana F, Podda GM, Cattaneo M.

Intern Emerg Med. 2009 Oct;4(5):443-4. doi: 10.1007/s11739-009-0292-x. Epub 2009 Aug 5. No abstract available.

PMID:
19655224
36.

Dronedarone in atrial fibrillation.

Pugliano M, Costantino G, Podda GM; Gruppo di Autoformazione Metodologica.

N Engl J Med. 2009 Jun 4;360(23):2479-80; author reply 2480-1. No abstract available.

PMID:
19504762
37.
38.

Abnormalities of homocysteine and B vitamins in the nephrotic syndrome.

Podda GM, Lussana F, Moroni G, Faioni EM, Lombardi R, Fontana G, Ponticelli C, Maioli C, Cattaneo M.

Thromb Res. 2007;120(5):647-52. Epub 2007 Feb 5.

PMID:
17276499
39.

New approaches for measuring coagulation.

Barrowcliffe TW, Cattaneo M, Podda GM, Bucciarelli P, Lussana F, Lecchi A, Toh CH, Hemker HC, Béguin S, Ingerslev J, Sørensen B.

Haemophilia. 2006 Jul;12 Suppl 3:76-81. Review.

PMID:
16684000
40.

Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors.

Cristalli G, Podda GM, Costanzi S, Lambertucci C, Lecchi A, Vittori S, Volpini R, Zighetti ML, Cattaneo M.

J Med Chem. 2005 Apr 21;48(8):2763-6.

PMID:
15828813
41.

Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.

Martinelli I, Taioli E, Battaglioli T, Podda GM, Passamonti SM, Pedotti P, Mannucci PM.

Arch Intern Med. 2003 Dec 8-22;163(22):2771-4.

Supplemental Content

Loading ...
Support Center